Evidence map›Paper›PMID 28120842›Full record

ReviewMucosal immunology2017

Gut permeability and mucosal inflammation: bad, good or context dependent.

R Ahmad, M F Sorrell, S K Batra, P Dhawan, A B Singh

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Mucosal immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05780723 (A Randomized Controlled Study of Qinghua Quyu Prescription Rectal Instillation for the Treatment of Ulcerative Colitis), which is not on this map. Cited by 136 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05780723 nacompletednot on this mapstarted 2023, after this paper: background citation

A Randomized Controlled Study of Qinghua Quyu Prescription Rectal Instillation for the Treatment of Ulcerative Colitis

TypeinterventionalSponsorBeijing Hospital of Traditional Chinese MedicineRan2023 to 2024Enrolled60ConditionsUlcerative ColitisArmsTreatment group: Rectal instillation of QHQYP, Control group: Mesalazine enema treatment
3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 1 synthesis or guideline pooled it, 232 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Implications of leaky gut in cattle.Animal frontiers : the review magazine of animal agriculture · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R AhmadDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, Nebraska, USA.
M F SorrellDepartment of Internal Medicine, Omaha, Nebraska, USA.
S K BatraDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, Nebraska, USA.
P DhawanDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, Nebraska, USA.
A B SinghDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, Nebraska, USA.
University of Nebraska Medical Center · USUniversity of Nebraska at Omaha · US

Funding

Role of Claudin-2 in Inflammatory Diseases and Colon CancerR01DK088902 · NIDDK · VANDERBILT UNIVERSITY · PI SINGH, AMAR B · 2011 to 2015
$1.7M
Role of Claudin-1 in Colon CancerI01BX002086 · VA · VETERANS HEALTH ADMINISTRATION · PI DHAWAN, PUNITA · 2013 to 2022
–
Role of Claudin-2 in Colon TumorigenesisI01BX002761 · VA · OMAHA VA MEDICAL CENTER · PI SINGH, AMAR B · 2016 to 2023
–
BLRD VA I01 BX002086BLRD VA I01 BX002761NIDDK NIH HHS R01 DK088902
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a multifactorial disease. A breach in the mucosal barrier, otherwise known as "leaky gut," is alleged to promote mucosal inflammation by intensifying immune activation. However, interaction between the luminal antigen and mucosal immune system is necessary to maintain mucosal homeostasis. Furthermore, manipulations leading to deregulated gut permeability have resulted in susceptibility in mice to colitis as well as to creating adaptive immunity. These findings implicate a complex but dynamic association between mucosal permeability and immune homeostasis; however, they also emphasize that compromised gut permeability alone may not be sufficient to induce colitis. Emerging evidence further supports the role(s) of proteins associated with the mucosal barrier in epithelial injury and repair: manipulations of associated proteins also modified epithelial differentiation, proliferation, and apoptosis. Taken together, the role of gut permeability and proteins associated in regulating mucosal inflammatory diseases appears to be more complex than previously thought. Herein, we review outcomes from recent mouse models where gut permeability was altered by direct and indirect effects of manipulating mucosal barrier-associated proteins, to highlight the significance of mucosal permeability and the non-barrier-related roles of these proteins in regulating chronic mucosal inflammatory conditions.

Indexed as

Immunity, MucosalAdaptive ImmunityAnimalsColitisDisease Models, AnimalHomeostasisHumansInflammatory Bowel DiseasesIntestinal MucosaIntestinesMicePermeability

Identifiers

PMID28120842
PMCPMC6171348
OpenAlexW2580420191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.